Potential Role of Autoantibodies Belonging to the Immunoglobulin G-3 Subclass in Cardiac Dysfunction Among Patients With Dilated Cardiomyopathy (original ) (raw )Immunoglobulin Adsorption in Patients With Idiopathic Dilated Cardiomyopathy
rudolf kunze
Circulation, 2000
View PDFchevron_right
Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy
Gerd Wallukat
Journal of the American College of Cardiology, 2000
View PDFchevron_right
Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption
Gerd Wallukat
International Journal of Cardiology, 1996
View PDFchevron_right
Immunohistological Changes in Dilated Cardiomyopathy Induced by Immunoadsorption Therapy and Subsequent Immunoglobulin Substitution
Gerd Wallukat
Circulation, 2001
View PDFchevron_right
Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up
Gerd Wallukat
International Journal of Cardiology, 2004
View PDFchevron_right
Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting
Najma Latif
Journal of the American College of Cardiology, 1993
View PDFchevron_right
Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies
Alida Caforio
Lupus, 2005
View PDFchevron_right
Investigation of autoantibodies directed against tissue-specific myocardial antigens in dilated cardiomyopathy
Дмитрий Рябенко
Биополимеры и …, 1995
View PDFchevron_right
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy
Oberdan Parodi
Journal of The American College of Cardiology, 1990
View PDFchevron_right
Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy
Noel Rose
Journal of the American College of Cardiology, 1990
View PDFchevron_right
High proportion of patients with end-stage heart failure regardless of aetiology demonstrates anti-cardiac antibody deposition in failing myocardium: humoral activation, a potential contributor of disease progression
Jose Flores
European heart journal, 2014
View PDFchevron_right
Autoimmunity in dilated cardiomyopathy
Bernhard Maisch
Heart Failure Reviews, 1996
View PDFchevron_right
Effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy
Ziya Kaya
Journal of Clinical Apheresis, 2010
View PDFchevron_right
Non-specific removal of antibodies in patients with idiopathic dilated cardiomyopathy: implications for xenotransplantation
Gerd Wallukat
The Journal of Heart and Lung Transplantation, 2004
View PDFchevron_right
Detection of antibodies in cardiac autoimmunity
Joris Delanghe
Clinica Chimica Acta, 2009
View PDFchevron_right
Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy
Wolfgang Hoffmann
American Heart Journal, 2010
View PDFchevron_right
Retrospective and perspectives in the immunology of cardiac diseases
Bernhard Maisch
Springer seminars in immunopathology, 1989
View PDFchevron_right
Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy
Andreas Mügge
Clinical Research in Cardiology, 2010
View PDFchevron_right
Anti-$beta;-adrenoceptor autoantibodies with $beta;-adrenergic agonistic activity in human dilated cardiomyopathy (DCM): Localization of two epitopes
Gerd Wallukat
Journal of Molecular and Cellular Cardiology, 1992
View PDFchevron_right
Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy
Alida Caforio
Journal of Clinical Pathology, 1999
View PDFchevron_right
Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity?
Alida Caforio
Journal of Autoimmunity, 1990
View PDFchevron_right
Cardiomyopathy - An approach to the autoimmune background
Gerd Wallukat
Autoimmunity reviews, 2017
View PDFchevron_right
IgG anti-cardiomyocyte antibodies in giant cell myocarditis
Matthew Pincus
Annals of clinical and laboratory science, 2008
View PDFchevron_right
Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome
Juan Figueroa
PROTEOMICS - Clinical Applications, 2012
View PDFchevron_right
Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression
Alida Caforio
1997
View PDFchevron_right
Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy
Irvin Goldenberg
Circulation Research, 1989
View PDFchevron_right
Autoantibodies in Heart Failure and Cardiac Dysfunction
Ziya Kaya
Circulation Research, 2012
View PDFchevron_right
Passive transfer of affinity-purified anti-heart autoantibodies (AHA) from sera of patients with myocarditis induces experimental myocarditis in mice
Alida Caforio
International Journal of Cardiology, 2015
View PDFchevron_right
The Effect of Intravenous Immunoglobulins on the Progression of Experimental Autoimmune Myocarditis in the Rat
Gad Keren
Experimental and Molecular Pathology, 2001
View PDFchevron_right
Immunoglobulin Isotype Determines Pathogenicity in Antibody-Mediated Myocarditis in Naive Mice
lionel zuckier
Circulation Research, 2000
View PDFchevron_right
Fcγ-Receptor IIa Polymorphism and the Role of Immunoadsorption in Cardiac Dysfunction in Patients With Dilated Cardiomyopathy
Wolfgang Hoffmann
Clinical Pharmacology & Therapeutics, 2010
View PDFchevron_right
Assessment of immune modulation of β-adrenergic pathways in human dilated cardiomyopathy: Influence of methodologic factors
Irvin Goldenberg
American Heart Journal, 1992
View PDFchevron_right
Discovering novel targets for autoantibodies in dilated cardiomyopathy
Cornelia Deeg
ELECTROPHORESIS, 2008
View PDFchevron_right
Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease‐associated protein chip
Derek Murphy
PROTEOMICS, 2006
View PDFchevron_right